Myanmar Pharmaceuticals & Healthcare Q4 2018
The weak regulatory landscape and limited affordability of medicines will continue to present headwinds topharmaceutical investment. At the same time, the underdeveloped state of the public health sector will shape commercialopportunities for private healthcare providers. Despite this, the upcoming rollout of universal healthcare coverage will improve long-term opportunities for investment in Myanmar’s pharmaceutical and healthcare sectors.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook